Sage Therapeutics (NASDAQ:SAGE) Releases Earnings Results, Hits Estimates
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) announced its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($1.53) EPS for the quarter, meeting the consensus estimate of ($1.53), Briefing.com reports. The firm had revenue of $11.87 million for the quarter, compared to analyst estimates of $10.80 million. Sage Therapeutics had a negative return on […]
More Stories
Middlefield Banc (NASDAQ:MBCN) Upgraded at StockNews.com
StockNews.com upgraded shares of Middlefield Banc (NASDAQ:MBCN – Free Report) from a sell rating to a hold rating in a...
StockNews.com Begins Coverage on Origin Agritech (NASDAQ:SEED)
StockNews.com started coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a report published on Saturday. The firm...
Mastech Digital (NYSE:MHH) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Mastech Digital (NYSE:MHH – Free Report) in a research report report published on Saturday....
StockNews.com Upgrades VF (NYSE:VFC) to Hold
StockNews.com upgraded shares of VF (NYSE:VFC – Free Report) from a sell rating to a hold rating in a report...
Aptiv (NYSE:APTV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Aptiv (NYSE:APTV – Free Report) in a research report sent to investors on Saturday....
Amprius Technologies (NYSE:AMPX) vs. Ilika (OTCMKTS:ILIKF) Financial Analysis
Amprius Technologies (NYSE:AMPX – Get Free Report) and Ilika (OTCMKTS:ILIKF – Get Free Report) are both industrials companies, but which...